Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 意见
• 07/18/23
0
0
嵌入
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论